Chinese delegation at RIVM Xu Ke, Vice Minister National Health and Family Planning Commission of the People’s Republic of China, visited RIVM at its premises at Bilthoven on July 15th 2013.
Jaap van Dissel appointed as Director of the RIVM Centre for Infectious Disease Control Prof Jaap van Dissel is appointed as Director of the RIVM Centre for Infectious Disease Control. He takes up the post on 15 August and succeeds Prof.
Extra measles vaccinations for risk groups Some areas of the Netherlands where families for religious reasons chose not to get their babies vaccinated are now reporting cases of measles, and it is expected that the number of cases will incr
Fewer municipalities with low vaccination coverage In the Netherlands, there are 80 municipalities with a low vaccination coverage for one or more vaccinations. This is a decrease compared to last year when there were still 90 municipalities.
More people visiting STI clinics in 2012 with chlamydia and gonorrhea infections In 2012, the number of new consultations at Sexually Transmitted Infections (STI) clinics in the Netherlands increased by 7% over the previous year.
New RIVM-method used to detect influenza A (H7H9) population immunity The level of immunity to the recently circulating H7N9 influenza virus in an urban and rural population in Vietnam is very low, according to the first population level study to examine human immuni
Regulation of nanomaterials needs more than definition alone In a new publication, RIVM indicates scientific challenges in the use of the EU definition for nanomaterial in legislation.
ICP M&M meetings in 2013 The 23rd CCE Workshop and 29th Task Force Meeting of the ICP M&M will be held 8-11 April 2013 in Copenhagen, Denmark.
Call for data on "no net loss of biodiversity" The CCE is pleased to publicate an announcement and a detailed substantiation and technical description of the call for data on “no net loss of biodiversity” which has been adopted at the 31st meet
EC-definition of nanomaterial provides proper basis In recent years, an increasing number of applications and products containing or using nanomaterials have become available.